One sector of the Stock Market, quietly gaining attention these days from Market makers and from many hedge fund managers, is that of biotechnology.
Read more...
One sector of the Stock Market, quietly gaining attention these days from Market makers and from many hedge fund managers, is that of biotechnology.
Read more...
Find the best discount broker for you, by looking at SmartMoney's 2009 Broker Survey. Compare 16 different discount brokers in 6 different categories.
Read more...
Many people invest their money in the market, while some people only pay attention to the cost per transaction, there is really much more to it when picking out an onlin
Read more...
Oil refinery stocks are on the verge of a breakout. The reason for this has nothing to do with the price or demand for oil.
Read more...
For investors, the proper interpretation of stock chart patterns is both an art and a science.
Read more...
Recently, I've been talking with a friend who is the same age as me (29,30) about investing. With stocks plummeting like the Titanic after ramming an ice berg, young people need to pay attention.
Read more...
When to Really Start Buying Stocks and Shares Again
On an almost daily basis some financial website has an article entitled something like “Is it Time to Buy Stocks?” In these times of distress everyo
Read more...
This site has it all, from what to expect from the stock market, to creating your portfolio. Chalk full of articles from experts, or interviews with experts, on how to do better with your stocks.
Read more...
One of the most important and effective ways of getting free traffic to your Xombytes and Xomblurbs is through writing short articles.
Read more...
Clorox stock went up 2.8% after news of buying out Burt's Bees went public. The natural products market has been steadily rising and Clorox wants in on the action.
Read more...
ImClone, the maker of cancer drug Erbitux, has been offered $60 a share from Bristol Myers Squibb.
Read more...